While our study supports its tumor-suppressive function in CRC through PPARγ-mediated inhibition of Wnt/β-catenin signaling and suppression of PKM2-driven glycolysis, contrasting roles have been reported in other cancers. This evidence concerns the gene PPARG and cancer.